AUG 13, 2026 · PHASE 4 TRIAL
Impact of Intravenous Iron Repletion On Mechanisms of Exercise InTolerance in HFpEF (IRONMET-HFpEF)
ClinicalTrials.gov
This is a Phase 4 registry record with planned enrollment of 65 participants and no reported results; it describes an active interventional trial measuring peak VO2 as a surrogate endpoint, but outcomes have not yet been posted.
Reported
Planned sample size65
Study phasePHASE4
Primary outcome measureChange in peak oxygen uptake (peak VO2) fro…